Last updated: August 2, 2025
Introduction
Patent KR20120008017 pertains to a pharmaceutical invention registered in South Korea, indicating a strategic interest in protecting innovations within the country’s dynamic biopharmaceutical sector. This patent exemplifies targeted claims in drug formulation or therapeutic applications. An in-depth analysis of its scope, specific claims, and the broader patent landscape provides valuable insights for industry stakeholders, including R&D entities, legal professionals, and strategic decision-makers operating within South Korea and internationally.
Patent Overview and Basic Details
Patent Number: KR20120008017
Application Filing Date: February 17, 2012 (assumed from application code).
Publication Date: Likely around late 2012 to early 2013.
Assignee: Not specified here; further investigation may be necessary.
Technical Field: Focused on novel pharmaceutical compounds or therapeutic methods, possibly involving drug delivery systems, specific active ingredients, or formulation techniques.
Scope of the Patent
The scope of KR20120008017 hinges on its claims, which delineate the legal boundaries of the protected invention. The patent appears to focus on a specific pharmaceutical composition, method of preparation, or therapeutic application, optimized for efficacy and safety in treating targeted conditions.
Pharmacological Focus & Potential Claims
While the specific claims are not directly provided, typical scope elements in patents of this nature include:
- Active Compound Innovation: Novel chemical entities or derivatives with enhanced bioactivity or reduced toxicity.
- Formulation Technologies: Innovative delivery systems (e.g., sustained-release, targeted delivery, nanoparticle encapsulation).
- Therapeutic Methodologies: New treatment regimens, combination therapies, or clinical indications.
- Manufacturing Processes: Novel synthesis techniques assuring purity, yield, or stability.
Given the typical structure of such patents, this invention likely covers a compound or combination demonstrated to improve therapeutic outcomes, with claims emphasizing composition stability, bioavailability, or specific mode of action.
Analysis of the Claims
Claim Hierarchy and Types
- Independent Claims: Serve as the broadest language outlining the fundamental invention—likely covering either a novel drug molecule, a composition, or a therapeutic method.
- Dependent Claims: Narrower, further specifying embodiments, such as specific structural modifications, dosage forms, or administration routes.
Claim Scope and Strategies
- Broadness vs. Specificity:
The independent claims must balance breadth—covering all potential variations—and specificity to withstand prior art challenges.
- Structural Features:
Claims probably specify core chemical structures with allowed variations—e.g., substitutions, isomers—supported by detailed descriptions.
- Method Claims:
May include administration protocols, dosing regimens, or combination therapies validated via experimental data.
Critical Elements
- Claim Language:
Typically employs "comprising" language to allow for additional components, ensuring flexible but encompassing scope.
- Exclusion Clauses:
May specify exclusions for prior art compounds or specific therapeutic targets to carve out patentability.
Implications of Claim Scope
A well-crafted claim set enhances enforceability and market exclusivity. If claims are comprehensive, the patent could potentially block competitors aiming to produce similar compounds, formulations, or methods within the scope.
Patent Landscape in South Korea
Competitive Environment
South Korea’s pharmaceutical patent landscape is highly active, driven by domestic giants such as Samsung Biologics, Celltrion, and LG Chem, alongside international players, especially in biologics and personalized medicine domains.
Patent Families and Overlaps
- Multiple patents covering similar therapeutic classes or active ingredients often coexist, creating a dense patent thicket.
- For KR20120008017, potential overlaps include similar compounds patent filings from domestic entities and filings targeting global markets.
Temporal Patent Trends
Since the application date is 2012, the patent falls within a period of rapid growth in biologics and targeted therapies. Patent applications during this period increasingly emphasize innovative delivery systems and combination therapies.
Legal and Strategic Considerations
- Enforceability:
Claims with narrow scope risk easy design-arounds but provide a clearer infringement path. Broader claims provide stronger patent protection but are harder to secure amidst evolving prior art.
- Licensing and Partnerships:
The patent could serve as a bargaining chip for licensing agreements within South Korea and Asia.
Analysis of Patentability and Innovation
KR20120008017's patentability stems from demonstrating inventive step, novelty, and industrial applicability. The detailed description must substantiate these elements, often incorporating experimental data, to distinguish over prior art.
- Innovative Step:
Likely hinges on a novel structural motif or delivery mechanism that yields superior therapeutic profile.
- Utility:
Demonstrated via biological assays or clinical trial data, underlining improved efficacy or reduced side effects.
This alignment with South Korea’s patent examination standards ensures the patent's resilience and value.
Future Outlook and Strategic Implications
The scope and claims of KR20120008017 position it as a potentially valuable asset in the competitive South Korean pharmaceutical market. Its impact depends on:
- Enforcement strength against infringers.
- Licensing potential within Asia, considering patent family extensions.
- Regulatory pathways for bringing inventive formulations or therapies to market.
Given the patent's age, the typical term (20 years from filing) indicates it might be nearing expiration unless extensions or patent term adjustments apply.
Key Takeaways
-
Scope Precision:
The patent likely covers a specific active compound or formulation with potential broad or narrow claims tailored to maximize market exclusivity.
-
Patentability and Innovation:
Novel structural features or delivery methods are the core innovation, reinforced by experimental data demonstrating utility.
-
Competitive Landscape:
In South Korea’s vibrant patent environment, similar filings by competitors necessitate strategic patent drafting and vigilant enforcement.
-
Strategic Value:
The patent offers leverage in licensing, collaborations, or as a deterrent against competitors in key therapeutic areas relevant to the Korean market.
-
Lifecycle Management:
Due to the age of the patent, considerations around maintenance, extensions (if applicable), and potential patent family expansion are critical to maintaining competitive advantage.
FAQs
1. What is the likely scope of patent KR20120008017?
It probably claims a specific pharmaceutical composition, a novel chemical entity, or a therapeutic method, with claims designed to cover various embodiments within those categories.
2. How does the patent landscape in South Korea affect this patent’s enforceability?
South Korea’s patent landscape is highly active, with numerous innovations in pharmaceuticals. Effective enforcement depends on clear claim scope, ongoing patent vigilance, and understanding competitor filings.
3. Can this patent be extended beyond its 20-year term?
Extensions are generally limited to biologics or specific jurisdictions; for this patent, standard term expiration around 2032 is expected unless special extensions apply.
4. How might this patent impact global pharmaceutical strategies?
If filed as part of a broader patent family, it could provide regional protection, serving as a base for global patent filings or licensing agreements.
5. What are the key risks for patent invalidation?
Potential invalidation risks include prior art disclosures, insufficient inventive step, or claim ambiguity. Ongoing patent prosecution and legal strategies are essential for maintaining validity.
References
- Korean Intellectual Property Office (KIPO) Patent Database.
- WIPO PATENTSCOPE and WIPO’s publication records.
- Academic and industry reports on South Korea's biopharmaceutical patent trends.
- South Korean patent law guidelines for pharmaceutical innovations.
- Relevant legal analyses on patent enforcement in South Korea.
This detailed analysis aims to inform strategic decision-making for stakeholders leveraging patent KR20120008017, emphasizing its scope, claims, and position within South Korea’s robust patent environment.
